# Semaglutide reviews: what people report | PepVault

Source: https://pepvault.app/peptides/semaglutide/reviews

Last updated: 2026-11-19

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Peptides](https://pepvault.app/peptides) [Semaglutide](https://pepvault.app/peptides/semaglutide) Reviews

What people report

# Semaglutide reviews: what people report

Read November 19, 2026 41 people, 3 sites [Published by PepVault](https://pepvault.app/guides/how-we-research)

Of the 41 people whose Semaglutide write-ups we read, 33 describe a change they wanted (33 a change in weight or appetite; 2 a calmer gut), 1 noticed nothing and 28 describe something unwanted.

## What people report

33 of the 41 people describe at least one change they wanted. Each bar counts the people who named anything in that group, once each, out of all 41; the line under it says what they named, and how many named it. Each took it on its own.

- Weight and appetite 33 of 41 weight loss 22 · less appetite 16 · less food noise or fewer cravings 2
- Gut 2 of 41 a calmer gut 2
- Thinking, memory and mood 1 of 41 clearer, quicker thinking 1
- Other 8 of 41 lower blood sugar 8

## What went wrong or did nothing

28 of the 41 people describe something they didn’t want, and 1 noticed nothing at all.

- Noticed nothing at all 1 of 41
- Gut 19 of 41 nausea or an upset stomach 14 · diarrhoea 4 · burping or wind 3 · vomiting 3 · constipation 2 · gallbladder pain 2 · heartburn 2 · bloating 1 · pancreatitis 1
- Energy 6 of 41 tiredness 6
- Sleep 2 of 41 worse sleep 2
- Thinking, memory and mood 2 of 41 low mood or loss of pleasure 2
- Weight and appetite 1 of 41 muscle loss 1
- Skin and hair 1 of 41 itching 1
- Other 6 of 41 a higher resting heart rate 2 · feeling ill 2 · dizziness or low blood pressure 1 · food tasting different 1

Your report

## Taken Semaglutide? What did you notice?

One tap to start. About 30 seconds, no account.

<!--promo-->

PepVault for iPhone

## Taking Semaglutide? Keep your own record

Log each dose and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=reviews-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## When people say it begins

6 of the 41 people say when they first noticed something; 35 don’t.

- On the first day 3 of 41
- In the first week 3 of 41

### What people took it for

22 of the 41 people say what they took it for; 19 don’t.

- Type 2 diabetes 14 of 41
- Weight loss 5 of 41
- Health and longevity 2 of 41
- Appetite control 1 of 41

## How it’s thought to work

Shown in people

Semaglutide is a long-lasting copy of GLP-1, a gut hormone released after a meal. It slows the stomach, makes a meal fill you sooner, quiets hunger in the brain and helps the pancreas release insulin when blood sugar rises. Controlled trials in people showed it lowers body weight, blood sugar and the risk of heart attacks and strokes; it is approved as Ozempic and Rybelsus for type two diabetes and as Wegovy for weight loss.

Sources: [Wilding et al., 2021: STEP 1, weight in adults without diabetes](https://pubmed.ncbi.nlm.nih.gov/33567185/); [Marso et al., 2016: SUSTAIN-6, heart events in type two diabetes](https://pubmed.ncbi.nlm.nih.gov/27633186/); [Lincoff et al., 2023: SELECT, heart events in obesity without diabetes](https://pubmed.ncbi.nlm.nih.gov/37952131/)

## What studies show

Our research section has 31 study pages on Semaglutide: 30 in people and 1 in mice.

[The first large trial for weight loss](https://pepvault.app/research/semaglutide-step-1-2021) gave 1961 adults without diabetes a weekly shot of semaglutide or a dummy shot for 68 weeks (STEP 1); their weight fell by 14.9% on average, against 2.4% on the dummy shot, and nausea and diarrhea were the commonest side effects.

- [Semaglutide: 11.85% more weight loss than placebo without diabetes](https://pepvault.app/research/semaglutide-tan-2022)
- [CagriSema: 18.4% weight loss vs 11.9% on semaglutide in REDEFINE 5](https://pepvault.app/research/cagrisema-redefine-5-2026)
- [CagriSema: HbA1c down 2.33% at 40 weeks in REIMAGINE 3](https://pepvault.app/research/cagrisema-reimagine-3-2026)
- [Semaglutide (oral): smaller HbA1c drop than orforglipron in ACHIEVE-3](https://pepvault.app/research/semaglutide-achieve-3-2026)
- [Semaglutide (oral) did not slow early Alzheimer's in evoke trials](https://pepvault.app/research/semaglutide-oral-evoke-and-evoke-2026)
- [Cagrilintide-semaglutide: 20.4% weight loss at 68 weeks in REDEFINE 1](https://pepvault.app/research/cagrilintide-redefine-1-2025)
- [CagriSema: 13.7% weight loss at 68 weeks in REDEFINE 2](https://pepvault.app/research/cagrisema-redefine-2-2025)
- [Semaglutide: 36% vs 0% hit glucose and weight goal in type 1 diabetes](https://pepvault.app/research/semaglutide-adjust-t1d-2025)
- [Semaglutide 25 mg pill: 13.6% weight loss at 64 weeks in OASIS 4](https://pepvault.app/research/semaglutide-oasis-4-2025)
- [Semaglutide (oral): fewer major heart events than placebo in SOUL](https://pepvault.app/research/semaglutide-oral-soul-2025)
- [Semaglutide: MASH resolved in 62.9% vs 34.3% on placebo at 72 weeks](https://pepvault.app/research/semaglutide-sanyal-2025)
- [Semaglutide 7.2 mg: 18.7% weight loss at 72 weeks in STEP UP](https://pepvault.app/research/semaglutide-step-up-2025)
- [Tirzepatide: 20.2% weight loss vs 13.7% on semaglutide at 72 weeks](https://pepvault.app/research/tirzepatide-surmount-5-2025)
- [Semaglutide: 24% lower risk of major kidney events in FLOW](https://pepvault.app/research/semaglutide-flow-2024)
- [Semaglutide: 10.2% weight loss at 208 weeks in SELECT](https://pepvault.app/research/semaglutide-select-2024)
- [Cagrilintide with semaglutide: 15.6% weight loss in type 2 diabetes](https://pepvault.app/research/cagrilintide-frias-2023)
- [Semaglutide pill: 15.1% weight loss at 68 weeks in OASIS 1](https://pepvault.app/research/semaglutide-oasis-1-2023)
- [Semaglutide: 6.5% vs 8.0% had a major heart event in SELECT](https://pepvault.app/research/semaglutide-select-2023)
- [Liraglutide: 6.4% weight loss vs 15.8% on semaglutide in STEP 8](https://pepvault.app/research/liraglutide-step-8-2022)
- [Cagrilintide with semaglutide: 17.1% weight loss at 2.4 mg, week 20](https://pepvault.app/research/cagrilintide-enebo-2021)
- [Semaglutide: 35% lower lunch energy intake vs placebo at 20 weeks](https://pepvault.app/research/semaglutide-friedrichsen-2021)
- [Semaglutide: 14.9% weight loss at 68 weeks in STEP 1](https://pepvault.app/research/semaglutide-step-1-2021)
- [Semaglutide 2.4 mg: 9.6% weight loss at 68 weeks in STEP 2](https://pepvault.app/research/semaglutide-step-2-2021)
- [Semaglutide: 16.0% weight loss at 68 weeks with therapy in STEP 3](https://pepvault.app/research/semaglutide-step-3-2021)
- [Semaglutide STEP 4: -7.9% weight vs +6.9% after switch to placebo](https://pepvault.app/research/semaglutide-step-4-2021)
- [Tirzepatide beat semaglutide 1 mg on HbA1c at 40 weeks in SURPASS-2](https://pepvault.app/research/tirzepatide-surpass-2-2021)
- [Semaglutide (oral): heart risk not higher than placebo in PIONEER 6](https://pepvault.app/research/semaglutide-oral-pioneer-6-2019)
- [Dulaglutide cut HbA1c and weight less than semaglutide in SUSTAIN 7](https://pepvault.app/research/dulaglutide-sustain-7-2018)
- [Exenatide ER: 0.9% HbA1c drop vs 1.5% with semaglutide in SUSTAIN 3](https://pepvault.app/research/exenatide-sustain-3-2018)
- [Semaglutide: 6.6% vs 8.9% heart or stroke events in SUSTAIN-6](https://pepvault.app/research/semaglutide-sustain-6-2016)
- [Retatrutide: 24.1% weight loss in MC4R-deficient mice over 21 days](https://pepvault.app/research/retatrutide-hitaka-2026)
- [Semaglutide in the library: how it works, half-life and evidence](https://pepvault.app/peptides/semaglutide)
- [Is Semaglutide legal? FDA, DEA and WADA status](https://pepvault.app/peptides/semaglutide/legal-status)
- [Semaglutide dose guide](https://pepvault.app/lab/dosage/semaglutide)

## Where the reports run ahead of the studies

Weight loss, less appetite, lower blood sugar and an upset stomach are what the controlled trials found too. Where the reports run ahead: 2 of the 41 people, both with long-standing bowel trouble, say their gut settled on semaglutide. No controlled trial has tested semaglutide for irritable bowel; one study of health records has looked at the drug class in it (PubMed, searched November 19, 2026).

## With these reports

### Semaglutide

- [Semaglutide: the full reference](https://pepvault.app/peptides/semaglutide)
- [Semaglutide dose guide](https://pepvault.app/lab/dosage/semaglutide)

### Mixing charts

- [2 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-2mg)
- [5 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-5mg)
- [10 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-10mg)

### Studies

- [Semaglutide: 11.85% more weight loss than placebo without diabetes](https://pepvault.app/research/semaglutide-tan-2022)
- [CagriSema: 18.4% weight loss vs 11.9% on semaglutide in REDEFINE 5](https://pepvault.app/research/cagrisema-redefine-5-2026)
- [CagriSema: HbA1c down 2.33% at 40 weeks in REIMAGINE 3](https://pepvault.app/research/cagrisema-reimagine-3-2026)
- [All 31 studies](https://pepvault.app/research#semaglutide)

### Compared with

- [Semaglutide vs Tirzepatide](https://pepvault.app/peptides/compare/semaglutide-vs-tirzepatide)
- [Retatrutide vs Semaglutide](https://pepvault.app/peptides/compare/retatrutide-vs-semaglutide)
- [Orforglipron vs Semaglutide](https://pepvault.app/peptides/compare/orforglipron-vs-semaglutide)
- [Cagrilintide vs Semaglutide](https://pepvault.app/peptides/compare/cagrilintide-vs-semaglutide)
- [Liraglutide vs Semaglutide](https://pepvault.app/peptides/compare/liraglutide-vs-semaglutide)
- [Semaglutide vs Dulaglutide](https://pepvault.app/peptides/compare/semaglutide-vs-dulaglutide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [GLP-1](https://pepvault.app/glossary/glp-1)

## Where the reports come from

41 people on 13 pages across 3 sites, written from August 2019 to August 2026. Read on November 19, 2026.

The largest single site, rapamycin.news, gave 23 of the 41.

Peptide Critic, which runs its forum, also runs a shop on its own site that sells injection pens and supplies, not peptides.

Millions of people take semaglutide on a prescription, and the few who write on these forums are a small corner of them who chose to write. The Diabetes UK posters took Ozempic on a prescription for type two diabetes; many rapamycin.news posters took small doses of the Rybelsus tablet for health rather than weight. We read the open threads with the most first-person reports and stopped there.

- [rapamycin.news forum, the thread on oral semaglutide (Rybelsus) in healthy people](https://www.rapamycin.news/t/intermittent-oral-rybelsus-semaglutide-use-in-healthy-individuals/642): 14 people
- [rapamycin.news forum, the “Experience with GLP-1s” thread](https://www.rapamycin.news/t/experience-with-glp-1s/15383): 8 people
- [Diabetes UK forum, “3 month Ozempic review”](https://forum.diabetes.org.uk/threads/3-month-ozempic-review.91337/): 4 people
- [Diabetes UK forum, a thread on the first weeks of Ozempic](https://forum.diabetes.org.uk/boards/threads/ozempic.100469/): 3 people
- [Diabetes UK forum, an Ozempic thread](https://forum.diabetes.org.uk/boards/threads/ozempic.106695/): 2 people
- [Diabetes UK forum, an early Ozempic thread](https://forum.diabetes.org.uk/boards/threads/ozempic.82513/): 2 people
- [Diabetes UK forum, a thread on a first Ozempic dose](https://forum.diabetes.org.uk/threads/ozempic.97871/): 2 people
- [Peptide Critic forum, a thread on a stalled weight loss](https://community.peptidecritic.com/topic/1000): 1 person
- [Peptide Critic forum, a thread on stacking tirzepatide and retatrutide](https://community.peptidecritic.com/topic/2228): 1 person
- [Peptide Critic forum, a thread where people tell their weight-loss story](https://community.peptidecritic.com/topic/2768): 1 person
- [Peptide Critic forum, a newcomer’s introduction](https://community.peptidecritic.com/topic/613): 1 person
- [Diabetes UK forum, “New to semaglutide (Ozempic)”](https://forum.diabetes.org.uk/threads/new-to-semaglutide-ozempic.92431/): 1 person
- [rapamycin.news forum, the “Tirzepatide” thread](https://www.rapamycin.news/t/tirzepatide-a-better-semaglutide-gip-glp1-agonism-also-ly3437943/3971): 1 person

### Read and not counted

- [Doctors and clinicians on rapamycin.news who give it to patients](https://www.rapamycin.news/t/intermittent-oral-rybelsus-semaglutide-use-in-healthy-individuals/642): Reports on patients from the people who prescribe it, not a person’s own, so not counted, even where they also wrote of their own use.
- **A rapamycin.news member who supplies GLP-1 drugs to clients**: The seller’s side of the counter, so not counted.
- **Reports about someone else (a cousin, a friend, a wife, a friend’s rat)**: Second-hand; only a person’s own report counts.
- **Posts about price, supply, pharmacies and where to buy**: Most posts in these threads; nothing noticed was said.
- **Posts where the change could not be put on semaglutide**: A poster who could not tell whether night-time trips to the toilet came from the drug or from high blood sugar, and posts naming the drug class without saying which drug.
- **Drugs.com user reviews**: The site refuses automated reads, so it was skipped.
- **Reddit and X**: Not part of this count.

## How we counted

We read every open write-up we could find by people who took Semaglutide, on its own page, and counted each person once however often they posted, including those who noticed nothing. Sellers, clinics, shop reviews and anyone who earns on a sale are not counted, and neither is a search result’s snippet; the list above names what we read and left out. Write-ups lean positive, because people who notice nothing rarely write about it and expecting an effect can produce one.

Spot an error? [feedback@pepvault.app](mailto:feedback@pepvault.app). [How we research](https://pepvault.app/guides/how-we-research). This page reports what people say; it is not medical advice.

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=reviews-card-next&mt=8)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking Semaglutide? Keep your own record

Log each dose and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=reviews-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking Semaglutide? Keep your own record

Log each dose and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=reviews-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With these reports

### Semaglutide

- [Semaglutide: the full reference](https://pepvault.app/peptides/semaglutide)
- [Semaglutide dose guide](https://pepvault.app/lab/dosage/semaglutide)

### Mixing charts

- [2 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-2mg)
- [5 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-5mg)
- [10 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-10mg)

### Studies

- [Semaglutide: 11.85% more weight loss than placebo without diabetes](https://pepvault.app/research/semaglutide-tan-2022)
- [CagriSema: 18.4% weight loss vs 11.9% on semaglutide in REDEFINE 5](https://pepvault.app/research/cagrisema-redefine-5-2026)
- [CagriSema: HbA1c down 2.33% at 40 weeks in REIMAGINE 3](https://pepvault.app/research/cagrisema-reimagine-3-2026)
- [All 31 studies](https://pepvault.app/research#semaglutide)

### Compared with

- [Semaglutide vs Tirzepatide](https://pepvault.app/peptides/compare/semaglutide-vs-tirzepatide)
- [Retatrutide vs Semaglutide](https://pepvault.app/peptides/compare/retatrutide-vs-semaglutide)
- [Orforglipron vs Semaglutide](https://pepvault.app/peptides/compare/orforglipron-vs-semaglutide)
- [Cagrilintide vs Semaglutide](https://pepvault.app/peptides/compare/cagrilintide-vs-semaglutide)
- [Liraglutide vs Semaglutide](https://pepvault.app/peptides/compare/liraglutide-vs-semaglutide)
- [Semaglutide vs Dulaglutide](https://pepvault.app/peptides/compare/semaglutide-vs-dulaglutide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [GLP-1](https://pepvault.app/glossary/glp-1)

<!--promo-->

PepVault for iPhone

## Taking Semaglutide? Keep your own record

Log each dose and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=reviews-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## Semaglutide

- [Semaglutide in the library](https://pepvault.app/peptides/semaglutide)
- [Is Semaglutide legal?](https://pepvault.app/peptides/semaglutide/legal-status)

## Research

- [Studies, in plain English](https://pepvault.app/research)
- [How we research](https://pepvault.app/guides/how-we-research)

## The library

- [The peptide reference library](https://pepvault.app/peptides)
- [Peptide comparisons](https://pepvault.app/peptides/compare)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
